| |
|
|
|
European Association for Cancer Research (EACR), Lyon
14-16 November 2023
This conference will focus on the most recent studies that have uncovered novel molecular pathways involved in response anticancer therapy. A panel of speakers involved in cutting-edge studies on the biological and cellular bases for therapeutic response in cancer will share their vision on how these disruptive discoveries could be exploited to rethink cancer therapies to ultimately improve therapeutics. Topics to be covered include: the role of mitochondrial homeostasis in therapy response; the latest and most disruptive advances in the molecular pharmacology of historical chemotherapeutic agents; the tumour microenvironment; experimental therapeutics in models systems; and more.
|
|
|
|
|
|
|
|
Organized by:
|
|
European Association for Cancer Research (EACR) |
|
|
Invited Speakers:
|
|
- Renata Basto (Institut Curie, France)
- Filipe Cabriero (MRC London Institute of Medical Sciences, UK)
- Huges de Thé (Institut Jean Bernard, France)
- Fanny Jaulin (Gustave Roussy, France)
- Valerie Lallemand-Breitenbach (INSERM, France)
- Scott Lowe (Memorial Sloan Kettering Cancer Center, USA)
- Fatima Mechta-Grigoriou (Institut Curie, France)
- Patrick Mehlen (Lyon Cancer Research Center, France)
- Yves Pommier (NCI Center for Cancer Research, USA)
- Sophie Postel-Vinay (IGR, France)
- Jean-Emmanuel Sarry (Centre de Recherches en Cancérologie de Toulouse, France)
- Clemens Schmitt (Max Delbruck Center, Germany)
- Jean Soulier (INSERM, France)
- Andreas Trumpp (German Cancer Research Centre, Germany)
- Celine Vallot (Institut Curie, France)
|
|
|
|
|
|
|
|
Deadline for Abstracts:
|
|
19 September 2023
|
|
|
|
|
|
|
|
Registration:
|
|
https://www.eacr.org/conference/cellularbases2023?utm_source=HUM&utm_medium=web&utm_campaign=CB23 Deadline: 17 October 2023
|
|
|
E-mail:
|
|
hannah.barrs@eacr.org
|
|
|
|
|
|
|
|
|